Cineverse Corp. Q2 FY25 10-Q Filing

Ticker: CNVS · Form: 10-Q · Filed: Nov 14, 2024 · CIK: 1173204

Sentiment: neutral

Topics: 10-Q, credit-facility, financials

TL;DR

Cineverse's Q2 10-Q is out. Credit facility at prime + 1.5%. Check financials.

AI Summary

Cineverse Corp. filed its 10-Q for the period ending September 30, 2024. The company's Line of Credit Facility bears interest at 1.5% above the prime rate. The filing details financial activities for the second quarter and first half of fiscal year 2025, including changes in Additional Paid-In Capital and Retained Earnings.

Why It Matters

This filing provides investors with an update on Cineverse Corp.'s financial health and operational activities for the second quarter of fiscal year 2025, including details on their credit facility.

Risk Assessment

Risk Level: medium — The filing contains financial data and operational updates that could impact the company's stock price, but does not indicate immediate severe financial distress.

Key Numbers

Key Players & Entities

FAQ

What is the interest rate on Cineverse Corp.'s Line of Credit Facility?

The Line of Credit Facility bears interest at a rate equal to 1.5% above the prime rate.

What is the reporting period for this 10-Q filing?

The Conformed Period of Report is 20240930, meaning the filing covers the period ending September 30, 2024.

When was this 10-Q filing submitted to the SEC?

The filing was submitted on 20241114.

What is the fiscal year end for Cineverse Corp.?

The fiscal year end for Cineverse Corp. is 0331.

What were the previous names of Cineverse Corp.?

Cineverse Corp. was formerly known as Cinedigm Corp., Cinedigm Digital Cinema Corp., and Access Integrated Technologies, Inc. d/b/a Cinedigm Digital Cinema Corp.

Filing Stats: 4,701 words · 19 min read · ~16 pages · Grade level 17.1 · Accepted 2024-11-14 17:00:25

Key Financial Figures

Filing Documents

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION Item 1. Condensed Consolidated Financial Statements (Unaudited) 1 Condensed Consolidated Balance Sheets at September 30, 2024 (unaudited) and March 31, 2024 1 Unaudited Condensed Consolidated Statements of Operations for the three and six months ended September 30, 2024 and 2023 2 Unaudited Condensed Consolidated Statements of Comprehensive (Loss) Income for the three and six months ended September 30, 2024 and 2023 3 Unaudited Condensed Consolidated Statements of Cash Flows for the six months ended September 30, 2024 and 2023 4 Unaudited Condensed Consolidated Statements of Equity for the three and six months ended September 30, 2024 and 2023 6 Notes to the Condensed Consolidated Financial Statements (Unaudited) 8 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 24 Item 4.

Controls and Procedures

Controls and Procedures 31

- OTHER INFORMATION

PART II - OTHER INFORMATION Item 1.

Legal Proceedings

Legal Proceedings 32 Item 1A.

Risk Factors

Risk Factors 32 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 32 Item 3. Defaults Upon Senior Securities 32 Item 4. Mine Safety Disclosures 32 Item 5. Other Information 32 Item 6. Exhibits 33 Exhibit Index 33

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION

FINANCIAL STATEMENTS (UNAUDITED)

ITEM 1. FINANCIAL STATEMENTS (UNAUDITED) Cineverse Corp. CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands, except share and per share data) As of September 30, 2024 March 31, 2024 (Unaudited) ASSETS Current Assets Cash and cash equivalents $ 2,429 $ 5,167 Accounts receivable, net of allowance for credit losses of $ 84 and $ 269 , respectively 14,814 15,106 Employee retention tax credit 79 1,671 Content advances 10,788 9,345 Other current assets 2,069 1,432 Total current assets 30,179 32,721 Property and equipment, net 2,932 2,276 Intangible assets, net 17,937 18,328 Goodwill 6,799 6,799 Content advances, net of current portion 1,472 2,551 Other long-term assets 1,281 1,703 Total Assets $ 60,600 $ 64,378 LIABILITIES AND STOCKHOLDERS' EQUITY Current Liabilities Accounts payable and accrued expenses $ 19,928 $ 20,817 Line of credit, including unamortized debt issuance costs of $ 180 and $ 81 , respectively 4,637 6,301 Current portion of deferred consideration on purchase of business 3,040 3,114 Term loan, including unamortized debt issuance costs of $ 87 and $ 0 , respectively 3,147 — Earnout consideration on purchase of business — 180 Current portion of operating lease liabilities 273 401 Deferred revenue 352 436 Total current liabilities 31,377 31,249 Deferred consideration on purchase of business, net of current portion — 457 Operating lease liabilities, net of current portion 371 462 Other long-term liabilities 61 59 Total Liabilities $ 31,809 $ 32,227 Commitments and contingencies (see Note 6) Stockholders' Equity Preferred stock, 15,000,000 shares authorized; Series A 10 % - $ 0.001 par value per share; 20 shares authorized; 7 shares issued and 7 shares outstanding at September 30, 2024 and March 31, 2024 3,559 3,559 Common Stock, $ 0.001 par value; Class A Stock: 275,0

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing